Redmile Group LLC 13D and 13G filings for Atara Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-13 4:01 pm Purchase | 2024-09-03 | 13G | Atara Biotherapeutics, Inc. ATRA | Redmile Group LLC | 579,541 9.900% | 167,485 (+40.65%) | Filing |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Redmile Group LLC | 412,056 9.900% | 18,557 (+4.72%) | Filing |
| 2023-02-14 4:18 pm Purchase | 2022-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Redmile Group LLC | 393,500 9.900% | 29,551 (+8.12%) | Filing |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Redmile Group LLC | 363,949 9.900% | 49,404 (+15.71%) | Filing |
| 2021-02-16 4:09 pm Purchase | 2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Redmile Group LLC | 314,545 9.900% | 94,780 (+43.13%) | Filing |